Bank of Montreal’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-8,932
| Closed | -$169K | – | 4437 |
|
2019
Q3 | $169K | Sell |
8,932
-12,496
| -58% | -$236K | ﹤0.01% | 2555 |
|
2019
Q2 | $252K | Buy |
21,428
+6,089
| +40% | +$71.6K | ﹤0.01% | 2388 |
|
2019
Q1 | $209K | Sell |
15,339
-1,207
| -7% | -$16.4K | ﹤0.01% | 2340 |
|
2018
Q4 | $169K | Buy |
16,546
+423
| +3% | +$4.32K | ﹤0.01% | 2399 |
|
2018
Q3 | $269K | Sell |
16,123
-8
| -0% | -$133 | ﹤0.01% | 2337 |
|
2018
Q2 | $255K | Buy |
16,131
+414
| +3% | +$6.55K | ﹤0.01% | 2367 |
|
2018
Q1 | $200K | Sell |
15,717
-21,164
| -57% | -$269K | ﹤0.01% | 2418 |
|
2017
Q4 | $422K | Buy |
36,881
+17,376
| +89% | +$199K | ﹤0.01% | 2135 |
|
2017
Q3 | $239K | Buy |
19,505
+15,362
| +371% | +$188K | ﹤0.01% | 2382 |
|
2017
Q2 | $47K | Sell |
4,143
-1,459
| -26% | -$16.6K | ﹤0.01% | 2953 |
|
2017
Q1 | $117K | Buy |
5,602
+5,424
| +3,047% | +$113K | ﹤0.01% | 2518 |
|
2016
Q4 | $4K | Hold |
178
| – | – | ﹤0.01% | 3486 |
|
2016
Q3 | $6K | Hold |
178
| – | – | ﹤0.01% | 3417 |
|
2016
Q2 | $4K | Sell |
178
-146
| -45% | -$3.28K | ﹤0.01% | 3522 |
|
2016
Q1 | $8K | Buy |
324
+114
| +54% | +$2.82K | ﹤0.01% | 3425 |
|
2015
Q4 | $7K | Hold |
210
| – | – | ﹤0.01% | 3487 |
|
2015
Q3 | $7K | Buy |
+210
| New | +$7K | ﹤0.01% | 3336 |
|